Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 3 August 2010
Vol. 3, Issue 133, p. ra58
[DOI: 10.1126/scisignal.2001180]
RESEARCH ARTICLES
HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis
Erik Slinger1,
David Maussang1,
Andreas Schreiber1,
Marco Siderius1,
Afsar Rahbar2,
Alberto Fraile-Ramos3,4,
Sergio A. Lira5,
Cecilia Söderberg-Nauclér2, and
Martine J. Smit1*
1 Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, the Netherlands. 2 Department of Medicine, Center for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, 171 76 Stockholm, Sweden. 3 Department of Molecular and Cell Biology, Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas, Campus Universidad Autonoma de Madrid, 28006 Madrid, Spain. 4 MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK. 5 Immunology Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Abstract:
US28 is a viral G protein (heterotrimeric guanosine triphosphate–binding protein)–coupled receptor encoded by the human cytomegalovirus (HCMV). In addition to binding and internalizing chemokines, US28 constitutively activates signaling pathways linked to cell proliferation. Here, we show increased concentrations of vascular endothelial growth factor and interleukin-6 (IL-6) in supernatants of US28-expressing NIH 3T3 cells. Increased IL-6 was associated with increased activation of the signal transducer and activator of transcription 3 (STAT3) through upstream activation of the Janus-activated kinase JAK1. We used conditioned growth medium, IL-6–neutralizing antibodies, an inhibitor of the IL-6 receptor, and short hairpin RNA targeting IL-6 to show that US28 activates the IL-6–JAK1–STAT3 signaling axis through activation of the transcription factor nuclear factor B and the consequent production of IL-6. Treatment of cells with a specific inhibitor of STAT3 inhibited US28-dependent [3H]thymidine incorporation and foci formation, suggesting a key role for STAT3 in the US28-mediated proliferative phenotype. US28 also elicited STAT3 activation and IL-6 secretion in HCMV-infected cells. Analyses of tumor specimens from glioblastoma patients demonstrated colocalization of US28 and phosphorylated STAT3 in the vascular niche of these tumors. Moreover, increased phospho-STAT3 abundance correlated with poor patient outcome. We propose that US28 induces proliferation in HCMV-infected tumors by establishing a positive feedback loop through activation of the IL-6–STAT3 signaling axis.
* To whom correspondence should be addressed. E-mail: mj.smit{at}few.vu.nl
Citation: E. Slinger, D. Maussang, A. Schreiber, M. Siderius, A. Rahbar, A. Fraile-Ramos, S. A. Lira, C. Söderberg-Nauclér, M. J. Smit, HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis. Sci. Signal.3, ra58 (2010).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
PODCASTS
Michael B. Yaffe and Annalisa M. VanHook (4 January 2011) Sci. Signal.4 (154), pc1.
[DOI: 10.1126/scisignal.2001786] |Abstract »|Full Text »|Podcast »
EDITORIAL GUIDES
Elizabeth M. Adler (9 November 2010) Sci. Signal.3 (147), eg11.
[DOI: 10.1126/scisignal.3147eg11] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
Wei Wong (7 September 2010) Sci. Signal.3 (138), ec270.
[DOI: 10.1126/scisignal.3138ec270] |Abstract »
PODCASTS
Martine J. Smit and Annalisa M. VanHook (3 August 2010) Sci. Signal.3 (133), pc16.
[DOI: 10.1126/scisignal.3133pc16] |Abstract »|Full Text »|Podcast »
RESEARCH ARTICLES
Deliang Guo, Robert M. Prins, Julie Dang, Daisuke Kuga, Akio Iwanami, Horacio Soto, Kelly Y. Lin, Tiffany T. Huang, David Akhavan, M. Benjamin Hock, Shaojun Zhu, Ava A. Kofman, Steve J. Bensinger, William H. Yong, Harry V. Vinters, Steve Horvath, Andrew D. Watson, John G. Kuhn, H. Ian Robins, Minesh P. Mehta, Patrick Y. Wen, Lisa M. DeAngelis, Michael D. Prados, Ingo K. Mellinghoff, Timothy F. Cloughesy, and Paul S. Mischel (15 December 2009) Sci. Signal.2 (101), ra82.
[DOI: 10.1126/scisignal.2000446] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
REVIEWS
Paul H. Huang, Alexander M. Xu, and Forest M. White (8 September 2009) Sci. Signal.2 (87), re6.
[DOI: 10.1126/scisignal.287re6] |Gloss »|Abstract »|Full Text »|PDF »
RESEARCH ARTICLES
Qi-Wen Fan, Christine Cheng, Zachary A. Knight, Daphne Haas-Kogan, David Stokoe, C. David James, Frank McCormick, Kevan M. Shokat, and William A. Weiss (27 January 2009) Sci. Signal.2 (55), ra4.
[DOI: 10.1126/scisignal.2000014] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
REVIEWS
S. Diane Hayward, Jianyong Liu, and Masahiro Fujimuro (16 May 2006) Sci. STKE2006 (335), re4.
[DOI: 10.1126/stke.3352006re4] |Gloss »|Abstract »|Full Text »|PDF »
Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non-Small Cell Lung Cancer with T790M Resistance Mutation.
S. M. Kim, O.-J. Kwon, Y. K. Hong, J. H. Kim, F. Solca, S.-J. Ha, R. A. Soo, J. G. Christensen, J. H. Lee, and B. C. Cho (2012)
Mol. Cancer Ther.
11, 2254-2264
|Abstract »|Full Text »|PDF »
Consensus on the role of human cytomegalovirus in glioblastoma.
K. Dziurzynski, S. M. Chang, A. B. Heimberger, R. F. Kalejta, S. R. McGregor Dallas, M. Smit, L. Soroceanu, C. S. Cobbs, and the HCMV and Gliomas Symposium (2012)
Neuro Oncology
14, 246-255
|Abstract »|Full Text »|PDF »
Significant Association of Multiple Human Cytomegalovirus Genomic Loci with Glioblastoma Multiforme Samples.
P. Ranganathan, P. A. Clark, J. S. Kuo, M. S. Salamat, and R. F. Kalejta (2012)
J. Virol.
86, 854-864
|Abstract »|Full Text »|PDF »
Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
N. Sen, X. Che, J. Rajamani, L. Zerboni, P. Sung, J. Ptacek, and A. M. Arvin (2012)
PNAS
109, 600-605
|Abstract »|Full Text »|PDF »
Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells.
J. Carlier, H. Martin, B. Mariame, B. Rauwel, C. Mengelle, H. Weclawiak, A. Coaquette, C. Vauchy, P. Rohrlich, N. Kamar, et al. (2011)
Blood
118, 6783-6792
|Abstract »|Full Text »|PDF »
Inhibition of Inflammatory Interleukin-6 Activity via Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase Signaling Antagonizes Human Cytomegalovirus Reactivation from Dendritic Cells.
Intragraft Cytomegalovirus Protein Expression Is Associated With Reduced Renal Allograft Survival.
M. Dzabic, A. Rahbar, K.-C. Yaiw, M. Naghibi, P. Religa, B. Fellstrom, E. Larsson, and C. Soderberg-Naucler (2011)
Clinical Infectious Diseases
53, 969-976
|Abstract »|Full Text »|PDF »
Human Cytomegalovirus US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype.
L. Soroceanu, L. Matlaf, V. Bezrookove, L. Harkins, R. Martinez, M. Greene, P. Soteropoulos, and C. S. Cobbs (2011)
Cancer Res.
71, 6643-6653
|Abstract »|Full Text »|PDF »
Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype.
K. Dziurzynski, J. Wei, W. Qiao, M. A. Hatiboglu, L.-Y. Kong, A. Wu, Y. Wang, D. Cahill, N. Levine, S. Prabhu, et al. (2011)
Clin. Cancer Res.
17, 4642-4649
|Abstract »|Full Text »|PDF »
Is Cytomegalovirus a Therapeutic Target in Glioblastoma?.